Academic Journal
Q1Helicobacter
About Helicobacter
Helicobacter is a scholarly journal published by Wiley-Blackwell Publishing Ltd. SCImago 2025 lists it in Q1, with an SJR of 1.079 and H-index of 99.
Coverage: 1996-2026. Research categories: Gastroenterology (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1).
Verified field sources
- Editor(s): Editor-in-Chief: Wai-Keung Leung; Associate Editors: Francis Megraud, Yi-Chia Lee, Richard Ferrero, Theodore Rokkas, Hong Lu, Raquel Mejías Luque, Byung-Wook Kim (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
- Journal Impact Factor: 4.6 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
Source-backed journal facts
Topics in published research
Helicobacter pylori-related gastroenterology studies; Microscopic Colitis; Clostridium difficile and Clostridium perfringens research; Gastric Cancer Management and Outcomes; Eosinophilic Esophagitis; Gastroesophageal reflux and treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,150.00 USD; 3,470.00 EUR; 2,720.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Population‐Level Trends in Gastric Cancer Mortality and Incidence After Expansion of Japanese National Health Insurance Coverage for Helicobacter pylori Eradication: A Descriptive Time‐Trend Study
Masahiro Asaka, Tokuma Tanuma, Akiko Kowada, Shouji Matsushima et al.
2026-09 · DOI: 10.1111/hel.70162Issue Information
2026-09 · DOI: 10.1111/hel.70143A Novel Helicobacter pylori Test Based on 16S rRNA Isothermal Amplification Point‐of‐Care Testing of Throat Swab
Ziyu Liu, Minqing Wu, Yanhong Li, Qiyu Huang et al.
2026-09 · DOI: 10.1111/hel.70164High Potency Proton Pump Inhibitor Versus Vonoprazan in Helicobacter pylori Triple Therapy
Mimi C. Tan, Robert L. Atmar, David Y. Graham
2026-07 · DOI: 10.1111/hel.70152Current Status of Diagnosis, Treatment, and Prevention of Helicobacter pylori Infection in China: A 2024–2025 National Multicenter Cross‐Sectional Study
Zhihao Yin, Zhiqiang Song, Xinlu Ren, Ye Chen et al.
2026-07 · DOI: 10.1111/hel.70151Antimicrobial Resistance Profile of Helicobacter pylori in Shenzhen, China: A Retrospective Study From 2021 to 2024
Fan Wu, Ye Chen, Chenghai Yang
2026-07 · DOI: 10.1111/hel.70154Local Price and Clarithromycin Resistance Shape the Cost of Vonoprazan Triple Therapy for Helicobacter pylori Eradication
Christos Zavos
2026-07 · DOI: 10.1111/hel.70160Active Helicobacter pylori Infection and Survival Outcomes in De Novo Metastatic Colorectal Cancer: A Retrospective Cohort Study
Sait Kitapli, Ali Alkan, Ozgur Tanriverdi
2026-07 · DOI: 10.1111/hel.70150A Decade of Screening and Treating Helicobacter pylori Infection Among First‐Year High School Students in Kyoto, Japan: Annual Trends in Infection, Consultation, and Eradication Success Rates (2015–2023)
Osamu Handa, Kazuhiko Uchiyama, Tomohisa Takagi, Yuji Naito et al.
2026-07 · DOI: 10.1111/hel.70156School‐Based Helicobacter pylori Screening for Adolescents in Japan: Current Status, Challenges, and Implications: A Narrative Review
Eisuke Kameoka, Hiroaki Saito, Takuto Hikichi, Jun Nakamura et al.
2026-07 · DOI: 10.1111/hel.70159Issue Information
2026-07 · DOI: 10.1111/hel.70142Worldwide Phylogenetic and Clinical Risk Association of the Helicobacter pylori Outer Membrane Gene hopQ
Edson I. Rubio‐Hernández, Ezequiel M. Fuentes‐Pananá, Kaisa Thorell, Yonne Nasimiyu et al.
2026-07 · DOI: 10.1111/hel.70145Bismuth–Amoxicillin–Vonoprazan Triple, Amoxicillin–Vonoprazan Dual, and Clarithromycin‐Based Triple Therapies for First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Open‐Label, Randomized Trial
Ping‐I Hsu, Ming‐Jen Sheu, Chien‐Lin Chen, Wei‐Yi Lei et al.
2026-07 · DOI: 10.1111/hel.7013114‐Day Vonoprazan–Minocycline Dual Therapy Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Single‐Center Randomized Controlled Noninferiority Trial
Tingting Yang, Ruijuan Xin, Yanhong Deng, Jun Liu et al.
2026-07 · DOI: 10.1111/hel.70153Diagnostic Value of the Pylori DuoTect Test for Helicobacter pylori Detection in the Vietnamese Population
Hang Dao Viet, Binh Nguyen Phuc, Thao Dang Thi, Trang Nguyen Thi Huyen et al.
2026-07 · DOI: 10.1111/hel.70155Diagnostic Accuracy of Serum Antibody, Urine Antibody, and Stool Antigen Tests for Helicobacter pylori in Japan: A Systematic Review and Meta‐Analysis
Chikamasa Ichita, Fumiaki Ishibashi, Yasuhiro Hagiwara, Ayaka Takasu et al.
2026-07 · DOI: 10.1111/hel.70157Evidence‐Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition
Chang Seok Bang, Seung Joo Kang, Hyunchul Lim, Seung Han Kim et al.
2026-07 · DOI: 10.1111/hel.70149First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran
Aryan Salahi‐Niri, Anahita Sadeghi, Marjan Mokhtare, Foroogh Alborzi Avanaki et al.
2026-05 · DOI: 10.1111/hel.70137Reviews
Community Reviews
Version History
September 25, 2026 at 7:55 am
September 25, 2026